127 related articles for article (PubMed ID: 8494390)
1. In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1993 Apr; 37(4):908-10. PubMed ID: 8494390
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of Ro 23-9424 against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1992 Nov; 36(11):2559-61. PubMed ID: 1489206
[TBL] [Abstract][Full Text] [Related]
3. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
[TBL] [Abstract][Full Text] [Related]
4. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
Edelstein PH; Hu B; Edelstein MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of quinupristin/dalfopristin (Synercid, RP 59500) against Legionella spp.
Edelstein PH; Edelstein MA
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):49-52. PubMed ID: 10744367
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
9. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
10. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
[TBL] [Abstract][Full Text] [Related]
11. In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1994 Feb; 38(2):200-4. PubMed ID: 8192443
[TBL] [Abstract][Full Text] [Related]
12. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
13. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
14. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
[TBL] [Abstract][Full Text] [Related]
15. Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Pankuch GA; Lichtenberger C; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Jul; 40(7):1653-6. PubMed ID: 8807057
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of ten macrolide, lincosamine and streptogramin drugs tested against Legionella species.
Johnson DM; Erwin ME; Barrett MS; Gooding BB; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):751-5. PubMed ID: 1425738
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.
Saito A; Sawatari K; Fukuda Y; Nagasawa M; Koga H; Tomonaga A; Nakazato H; Fujita K; Shigeno Y; Suzuyama Y
Antimicrob Agents Chemother; 1985 Jul; 28(1):15-20. PubMed ID: 3862361
[TBL] [Abstract][Full Text] [Related]
18. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Nakashio S; Iwasawa H; Iino S; Shimada J
Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Edelstein PH; Gaudet EA; Edelstein MA
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
[TBL] [Abstract][Full Text] [Related]
20. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
Fremaux A; Sissia G; Cohen R; Geslin P
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
